Navigation Links
iCAD to Present at America's Growth Capital 4th Annual Emerging Growth Conference
Date:9/12/2007

NASHUA, N.H., Sept. 12 /PRNewswire-FirstCall/ -- iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced that Ken Ferry, President and Chief Executive Officer of iCAD, will be presenting at the America's Growth Capital 4th Annual Emerging Growth Conference on Thursday, September 20th at 12:00 p.m. (Eastern Daylight Time) at the Sheraton Boston.

The presentation will be webcast live and archived for replay on the "Investors" section of the Company's Web site at http://www.icadmed.com.

An audio webcast of the presentation will also be available after the conference at http://www.wsw.com/webcast/agc6/icad/.

About iCAD, Inc.

iCAD, Inc. (Nasdaq: ICAD) is an industry-leading provider of Computer-Aided Detection (CAD) solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is entrusted with the task of early cancer detection by over one thousand women's healthcare centers worldwide. For more information, call +1 877 iCADnow or visit http://www.icadmed.com.

For iCAD, contact Darlene Deptula-Hicks, EVP and CFO at 603-882-5200 x7944 or via email at ddeptula@icadmed.com

For iCAD Investor Relations, contact Anne Marie Fields of Lippert/Heilshorn & Associates at 212-838-3777 x6604 o
'/>"/>

SOURCE iCAD, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
2. Researchers Present Ways To Reduce The Risk Of Dementia
3. Researchers Present Data Regarding The Efficiency Of Herbs
4. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
5. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
6. Drug Reactions First Present Themselves In The Mouth
7. Reminiscing Into The Past Makes You Dissatisfied With The Present
8. Living In The Past Indicates Dissatisfaction With Present
9. Movies Represent Coma In A Wrong Way
10. Onchocerciasis: Presentation And Treatment
11. Researchers Warn That Routine Physical Examination Could Miss Breech Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
...iabetes are at high risk of fatal and non-fatal my...he main reason for their decreased life expectancy...roxisome proliferator-activated receptor-? (PPAR-?...ns. Pioglitazone is one such agonist used to treat...
...nown to be capable of altering the emotional state...s of essential oils have been acknowledged in folk...us and lavender fragrances have been particularly ...s by aromatherapists. Recently a study, published ...
...ren’s Hospital of Boston have reconstructed defect...mbs. The researchers used amniotic fluid for growi...anted these living tissues into lambs, while they ...ering is used for altering birth defects. Undiffer...
...f Cardiology (ESC) is calling for concerted action...rt of the World Heart Organisation (WHO). // "Pr...arly demonstrates the full extent of the global bu...ovascular disease, cancer, chronic respiratory dis...
Other Medicine News:Health News:Aromatherapy: Ambient odors of orange and lavender reduce anxiety 2
(Date:10/9/2008)...ce Institute, Navigenics, Affymetrix and,Microsoft...Oct. 9 /- A consortium of health care...es in a first-of-its-kind,research study to assess...,on people who choose to receive such screenings t...tain diseases., Sponsored by Scripps Translationa...
(Date:10/8/2008)...rm Treatments for Spinal Cord, Other Nerve,Injurie... -- A protein that enables,nerve cells to communic...g,the developing nervous system. Research into how...ong nerve cells may provide a basis for eventual,t...r nervous system,including spinal cord injury., ...
(Date:10/8/2008)...luate TAXUS(R) Element(TM) Platinum Chromium ...Oct. 8 /- Boston Scientific... has completed enrollment in,the PERSEUS trial, de...TAXUS(R) Element(TM) paclitaxel-eluting coronary s...arly 1,500 patients at 100 U.S. and,international ...
(Date:10/7/2008)...re/ -- Prometheus Laboratories Inc., a,specialty p...om its,development of PROMETHEUS(R) IBS Diagnostic...l syndrome (IBS). The findings suggest measurable,...kers in blood samples,between IBS and non-IBS pati...ined with a proprietary algorithm, led to the deve...
Breaking Medicine Technology:Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 4Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 5Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Building efficient effective locally sensitive solutions for dementia care 3467 1Building efficient effective locally sensitive solutions for dementia care 3467 2New molecules discovered that block cancer cells from modifying cell DNA 758 1New molecules discovered that block cancer cells from modifying cell DNA 758 2ReBuilder Medical Technologies Inc Announces Agreement with Internet Marketer Helio Health 3B Anticipates 12 25 Additional Profit 3466 1ReBuilder Medical Technologies Inc Announces Agreement with Internet Marketer Helio Health 3B Anticipates 12 25 Additional Profit 3466 2ReBuilder Medical Technologies Inc Announces Agreement with Internet Marketer Helio Health 3B Anticipates 12 25 Additional Profit 3466 3VitalKey Introduces the Pink Key 28R 29 3464 1VitalKey Introduces the Pink Key 28R 29 3464 2
...finity and MedImmune to Present Preclinical Data F...CAMBRIDGE, Mass. and GAITHERSBURG, Md., April 10, ... Inc. (Nasdaq:INFI) and,MedImmune, Inc. (Nasdaq:ME...tudy with an oral formulation of IPI-504 in non-sm...the upcoming Annual,Meeting of the American Associ...
...ETHESDA, Md., April 10, 2007--In a study appearing...scientists supported by the,National Institutes of...loskeletal and Skin Diseases (NIAMS) have discover...flammatory skin,condition vitiligo, as well as a p... a chronic condition in which melanocytes (the cel...
Other Medicine Technology:Infinity and MedImmune to Present Preclinical Data From Study of,Oral Formulation of IPI-504 At AACR 2Infinity and MedImmune to Present Preclinical Data From Study of,Oral Formulation of IPI-504 At AACR 3Infinity and MedImmune to Present Preclinical Data From Study of,Oral Formulation of IPI-504 At AACR 4Scientists Implicate Gene in Vitiligo and Other Autoimmune Diseases 2Scientists Implicate Gene in Vitiligo and Other Autoimmune Diseases 3
Luer Rongeur
Friedman Rongeur
Zaufal-Jansen Ronguer
Mead Rongeur #1A
Medicine Products: